Splet24. jun. 2024 · June 24, 2024. Dr. Jessica Mary Clement. A switch maintenance therapy approach using the immune checkpoint inhibitor avelumab in patients with advanced urothelial carcinoma (UC) who had not progressed after induction platinum-based chemotherapy offered significantly improved survival outcomes, according to results of … Splet10. apr. 2024 · An increase in fentanyl in the illicit drug supply has further complicated buprenorphine initiation and maintenance. Current evidence underlying the best strategy for initiating and maintaining ...
Switch maintenance chemotherapy versus observation after
SpletSwitch maintenance therapy significantly prolonged PFS but not OS and, thus, should not be proposed to elderly patients with advanced NSCLC. Switch maintenance … Splet21. feb. 2024 · Switch maintenance therapy with pemetrexed or erlotinib is recommended in patients receiving platinum-based therapy without pemetrexed as induction therapy [1, 2, 6, 7]. However, patients with lung squamous cell carcinoma (SCC) receive little benefit from these maintenance strategies. in-laws relationship chart
Switch maintenance therapy with anlotinib after chemotherapy in ...
Splet12. mar. 2024 · Use of switch maintenance therapy with ICI after chemotherapy can potentially intensify immune elimination or enable immune system to prolong the … Splet24. sep. 2024 · Maintenance therapy can be divided into two categories, switch maintenance and continuation maintenance . A phase III trial indicates that switch … Splet31. jul. 2016 · In a randomized phase II trial using CIMAvax-EGF as switch maintenance or second-line therapy versus best supportive care in subjects with stage IIIB or IV NSCLC, a trend toward survival benefit was found. Patients younger than 60 years, those with good antibody response against EGF, and subjects in whom serum EGF concentration ([EGF ... in-laws scanner reason artificer